Global collaboration action for the development of vaccines for reducing the disease burden of Tuberculosis in sub-Saharan Africa
This funding program, under the Horizon Europe Framework, aims to reduce the burden of Tuberculosis in sub-Saharan Africa through global collaborative actions focused on vaccine development. It prioritizes accelerating the clinical development of new and licensed TB vaccine candidates and enhancing their availability and affordability in low-resource settings.
Who is Funded
This section outlines the types of organizations and geographical areas eligible for funding, focusing on collaborative efforts to combat Tuberculosis in sub-Saharan Africa. The program seeks to involve a broad range of entities from EU, associated, and African countries to achieve its global health objectives.
What is Funded
This section details the types of projects and research activities that are eligible for funding, specifically emphasizing clinical development of Tuberculosis vaccines and related data generation. The program supports impactful research that contributes to public health outcomes.
Type and Scope of Funding
This section outlines the financial mechanisms and scale of support provided, highlighting that the program primarily offers grants for collaborative research actions in vaccine development. Projects are expected to leverage significant co-contributions from partners.
Conditions and Requirements
This section details the essential criteria and regulations that applicants and beneficiaries must adhere to, ranging from consortium composition to the exploitation and accessibility of research outcomes. Key emphasis is placed on collaborative structures and ensuring public access to developed health technologies.
Application Procedure
This section outlines the structured, two-stage application process, detailing submission requirements, evaluation criteria, and how proposals are assessed based on their scientific merit, expected impact, and implementation quality.
Legal Basis
This section identifies the core legal and regulatory framework that underpins the funding program, ensuring its mandate and operational guidelines are clearly defined within the broader European Union legal landscape.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
15,300,000 €
Allocated Budget:
45,900,000 €
Award Channel:
Framework Programme Call
Region:
European Union Member States, Overseas Countries and Territories (OCTs) linked to EU Member States, Horizon Europe Associated Countries (including Albania, Armenia, Bosnia and Herzegovina, Canada, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, New Zealand, North Macedonia, Norway, Serbia, Tunisia, Turkey, Ukraine, United Kingdom), countries with association negotiations in process (Morocco, South Korea, Switzerland), and constituent states of the EDCTP Association (Benin, Burkina Faso, Cameroon, Côte d’Ivoire, Democratic Republic of the Congo, Ethiopia, Eswatini, Gabon, The Gambia, Ghana, Guinea-Bissau, Guinea-Conakry, Kenya, Liberia, Malawi, Mali, Mozambique, Niger, Nigeria, Republic of the Congo, Rwanda, Senegal, Sierra Leone, Somalia, South Africa, Tanzania, Uganda, Zambia, Zimbabwe). The primary focus for project activities is sub-Saharan Africa.
Sectors:
Healthcare, Research and Development, Pharmaceutical Industry, Other
Beneficiaries:
Adolescents, adults, pregnant and lactating women, new-borns, children, other vulnerable and neglected populations, and people with co-infections and co-morbidities at risk in sub-Saharan Africa.
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Commercialization
Funding Provider
Program Level:
Multi-Country
Funding Body:
Global Health EDCTP3 Joint Undertaking (JU)
Managed By:
Global Health EDCTP3 JU Programme Office
Additional Partners:
Contributing partners (providing financial and/or in-kind contributions), Team Europe Initiative on Manufacturing and Access to Vaccines, medicines and health products (TEI-MAV+), or similar African initiatives.
Website: